Related references
Note: Only part of the references are listed.Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China
Yunnan Zhang et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry
Felice Gragnano et al.
INTERNAL AND EMERGENCY MEDICINE (2021)
Ticagrelor or clopidogrel after acute coronary syndrome in the elderly: a propensity score matching analysis from 16 653 patients included in two large multinational registries
M Bianco et al.
EUROPEAN HEART JOURNAL (2021)
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry
Arturo Cesaro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Potent P2Y12 inhibitors versus Clopidogrel in elderly patients with acute coronary syndrome: Systematic review and meta-analysis
Tomohiro Fujisaki et al.
AMERICAN HEART JOURNAL (2021)
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI
Dominick J. Angiolillo et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2021)
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
Marco Valgimigli et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study
Christel Bruggmann et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2020)
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study
Jaya Chandrasekhar et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Reasons for early discontinuing or switching of antiplatelet therapy in elderly patients after acute coronary syndrome
Marieke E. Gimbel et al.
CORONARY ARTERY DISEASE (2020)
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
Marieke Gimbel et al.
LANCET (2020)
Comparison Between Ticagrelor and Clopidogrel in Elderly Patients With an Acute Coronary Syndrome Insights From the SWEDEHEART Registry
Karolina Szummer et al.
CIRCULATION (2020)
Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention
Jianan Li et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial
Naveen L. Pereira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry)
Paolo Calabro et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Prasugrel vs. Ticagrelor for Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
Muhammad Shahzeb Khan et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2019)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS (vol 39, pg 213, 2018)
M. Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice Results From the Bern Percutaneous Coronary Intervention Registry
Thomas Zanchin et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2018)
Letter by Aw et al Regarding Article, Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Jernice Wan Xin Aw et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
John A. Bittl et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome
Huidong Wang et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2016)
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
Felicita Andreotti et al.
EUROPEAN HEART JOURNAL (2015)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
East Asian Paradox: Challenge for the Current Antiplatelet Strategy of One-Guideline-Fits-All Races in Acute Coronary Syndrome
Young-Hoon Jeong
CURRENT CARDIOLOGY REPORTS (2014)
Prospective Treatment of Age-Related Diseases by Slowing Down Aging
Mikhail V. Blagosklonny
AMERICAN JOURNAL OF PATHOLOGY (2012)
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation A Report From the Swedish Atrial Fibrillation Cohort Study
Leif Friberg et al.
CIRCULATION (2012)
Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Gjin Ndrepepa et al.
CIRCULATION (2012)
Heart Disease and Stroke Statistics-2012 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2012)
Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes A Substudy From the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial
Steen Husted et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Age-related changes in liver structure and function: Implications for disease ?
DL Schmucker
EXPERIMENTAL GERONTOLOGY (2005)
Adjusted survival curves with inverse probability weights
SR Cole et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Aging and thrombosis
WR Wilkerson et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Share Paper
